Microdosing Results, Limitations, & Emerging Questions: A Conversation with Jim Fadiman
James Fadiman, PhD (Psychologist & Researcher)
Tuesday 9 September, 2025 8PM CEST (7PM BST, 2PM ET, 11AM PT)
Online via Zoom
Add to Calendar
Microdosing psychedelics has captured global attention in recent years, driven by powerful personal stories of enhanced mood, focus, and well-being. But what do we truly know about its effectiveness and safety?
In this session, we sit down with Dr. Jim Fadiman, early psychedelic researcher and co-author of Microdosing for Health, Healing, and Enhanced Performance, to explore the current state of knowledge, ongoing controversies, and the broader implications of this emerging practice.
Dr. Fadiman is known for his citizen science approaches to microdosing, collecting thousands of self-reports from individuals around the world. These accounts describe a wide range of improvements, from alleviating depression, chronic pain, and ADHD symptoms to supporting palliative care, creativity, and tapering off antidepressants. At the same time, any intervention claiming to affect so many conditions should invite rigorous scrutiny and appropriate research designs.
This conversation will explore the differences between self-reported outcomes and clinical trials, the confusion between high-dose and microdosing research results, and future directions to determine efficacy in different populations.
Unpack the Evidence
By joining this conversation, you’ll gain clarity on what microdosing can and can’t offer, grounded in both real-world accounts and rigorous science. You’ll walk away with:
- An understanding of citizen science and real-world evidence contributes to our current understanding of microdosing and better-focused clinical research and appropriate methodology.
- Insight into key areas of reported benefit, including mood, focus, and mental health, a growing number of physical conditions, alongside known risks and contraindications.
- Knowledge of ongoing challenges in research methodology, including the limitations of clinical trials and double-blind studies, and the need to develop more useful measuring tools better suited to analysing long-term psychedelic effects.
Designed for Enthusiasts and Practitioners Like You
If you want to engage with the current science and controversies around microdosing, this event is for you. You’ll get the most out of it if you:
- Are a researcher or clinician seeking actionable insights and fresh frameworks for your work.
- Work as a therapist or facilitator supporting clients who use or ask about microdosing.
- Have personal experience with microdosing and want to make sense of your own or others’ reports.
- Are a student, educator, or advocate seeking a deeper understanding of current debates.
Save your spot today and join a thoughtful, evidence-informed discussion with Dr. Jim Fadiman. Gain insights you can bring into your work, practice, or personal journey, and be part of shaping the conversation around microdosing.
